Spectrum Spine has acquired what it describes as a highly unique and proprietary surface technology for spinal trauma, called BIOBraille, and has begun operations with the device.
BIOBraille is a state-of-the-art surface technology with 14 related patents, exclusively licensed to Spectrum Spine. It integrates prescriptive laser technology and is designed to improve patient outcomes in spinal operations.
This surface technology will be added to Spectrum Spine’s portfolio of spinal solutions that includes the Bridge MIS tubular approach laminoplasty system, designed to preserve nerve, vasculature, and muscle tissue, reduce operative complications, and restore pain-free function.
Spectrum say that the technology holds great promise to provide unsurpassed bone growth activation in spinal and orthopaedic devices that may reduce inflammation, speed the process of strong and durable fusion, and lead to superior outcomes for patients having spinal surgery.
Jim Robinson, Spectrum’s founder and chief technical officer, said: “We are thrilled to add this game-changing, proprietary technology to the Spectrum Spine portfolio of innovative spinal implants and pleased to have the opportunity to bring Dr. Ganey’s brilliant work to clinical implementation.”